The superrich have always been interested in extending their lives, and today's elite are investing money in therapies for life extension. Venki Ramakrishnan's book *Why We Die* explores the biology of aging and potential interventions for extending lifespan. Private equity investments in aging research may distort priorities and hinder progress. Aging is closely linked to chronic diseases, and tackling aging as a whole may have multiple effects on age-related diseases. Diet, exercise, and sleep are currently the best interventions for longevity.
2 Comments
Sort: